The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moreno, S. E.
Right arrow Articles by Liew, F. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moreno, S. E.
Right arrow Articles by Liew, F. Y.
The Journal of Immunology, 2006, 177: 3218-3224.
Copyright © 2006 by The American Association of Immunologists, Inc.

IL-12, but Not IL-18, Is Critical to Neutrophil Activation and Resistance to Polymicrobial Sepsis Induced by Cecal Ligation and Puncture1

Susana E. Moreno*, José C. Alves-Filho*, Thais M. Alfaya*, João S. da Silva{dagger}, Sergio H. Ferreira* and Foo Y. Liew2,{ddagger}

* Department of Pharmacology, and {dagger} Department of Immunology, School of Medicine of Ribeirão Preto, University of São Paulo, São Paulo, Brazil; {ddagger} Department of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Scotland, United Kingdom


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Sepsis is a systemic inflammatory response resulting from local infection due, at least in part, to impaired neutrophil migration. IL-12 and IL-18 play an important role in neutrophil migration. We have investigated the mechanism and relative role of IL-12 and IL-18 in polymicrobial sepsis induced by cecal ligation and puncture (CLP) in mice. Wild-type (WT) and IL-18–/– mice were resistant to sublethal CLP (SL-CLP) sepsis. In contrast, IL-12–/– mice were susceptible to SL-CLP sepsis with high bacteria load in peritoneal cavity and systemic inflammation (serum TNF-{alpha} and lung neutrophil infiltration). The magnitude of these events was similar to those observed in WT mice with lethal CLP sepsis. The inability of IL-12–/– mice to restrict the infection was not due to impairment of neutrophil migration, but correlated with decrease of phagocytosis, NO production, and microbicidal activities of their neutrophils, and with reduction of systemic IFN-{gamma} synthesis. Consistent with this observation, IFN-{gamma}–/– mice were as susceptible to SL-CLP as IL-12–/– mice. Moreover, addition of IFN-{gamma} to cultures of neutrophils from IL-12–/– mice restored their phagocytic, microbicidal activities and NO production. Mortality of IL-12–/– mice to SL-CLP was prevented by treatment with IFN-{gamma}. Thus we show that IL-12, but not IL-18, is critical to an efficient host defense in polymicrobial sepsis. IL-12 acts through induction of IFN-{gamma} and stimulation of phagocytic and microbicidal activities of neutrophils, rather than neutrophil migration per se. Our data therefore provide further insight into the defense mechanism against this critical area of infectious disease.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Neutrophils migrate rapidly to the site of infection, where they are activated to release a range of microbicidal mediators (reviewed in Ref. 1). In addition, neutrophils also release cytokines and chemokines, which enhance their own recruitment and activation as well as inducing the migration of other immune cells (2). Our previous studies showed that lethal sepsis induced by cecal ligation and puncture (CLP)3 or Staphylococcus aureus inoculation is associated with reduction of neutrophil rolling, adhesion, and transmigration to sites of infection (3, 4, 5, 6, 7, 8). The impairment of neutrophil migration was also associated with high mortality and increased numbers of bacteria in peritoneal exudates and blood. Conversely, in nonlethal sepsis, the bacterial infection was restricted to the peritoneal cavity, and neutrophil rolling, adhesion, and migration were not affected, and no significant mortality was observed (3, 4, 5, 6, 7, 8). The mechanism involved in the paralysis of neutrophil migration function is still elusive. We and others have reported that IL-12 and IL-18 play an important role in neutrophil migration (9, 10, 11). We have now investigated the relative roles of IL-12 and IL-18 in an experimental polymicrobial sepsis in mice using the CLP models.

IL-12 is a heterodimeric proinflammatory cytokine (IL-12p70), consisting of a p35 and a p40 subunit, which is mainly produced by APCs (12, 13). It is a potent stimulator of T cell functions, driving the differentiation of naive CD4+ T cells into the Th1 lineage and the production of IFN-{gamma}, a potent activator of antimicrobial functions of phagocytes against a range of pathogenic microorganisms (13, 14). IL-12 is also important in the pathogenesis of autoimmune inflammatory diseases (15, 16) but its role in sepsis remains controversial. It has been reported that administration of anti-IL-12 antiserum increased the bacteria load following CLP or i.p. administration of Escherichia coli, suggesting that IL-12 contributes to an effective antibacterial defense (17, 18). In contrast, it has also been shown that polyclonal IL-12 Ab decreased mortality of mice after CLP or i.p. injection of live E. coli (17, 18, 19, 20).

IL-18 is produced by several cell types, including activated macrophages, dendritic cells, keratinocytes, osteoblasts, and intestinal epithelial cells (21, 22, 23). IL-18 is proinflammatory, inducing the release of TNF-{alpha}, IL-1beta, and chemokines such as CXCL-8 (24, 25, 26). Recent reports indicate an important role of IL-18 in the pathogenesis of several inflammatory diseases, including rheumatoid arthritis, psoriasis, inflammatory bowel disease, and sarcoidosis (27, 28, 29). It was also demonstrated that IL-18, acting synergistically with IL-12, IL-15, or microbial agents, stimulates T cells and NK cells from mice and humans to produce IFN-{gamma} (26, 30, 31). The role of IL-18 in sepsis remains controversial. It has been reported that IL-18-deficient mice exhibited reduced capacity to kill S. aureus, associated with increased severity of sepsis (32). In contrast, it was also reported that specific blockage of IL-18 protects mice from death induced by E. coli or Salmonella typhimurium administration (33) or endotoxemia (10, 34). Furthermore, patients with severe sepsis were reported to have elevated circulating levels of IL-18 (35). A possible explanation to these apparently contradictory results is that IL-18 and IL-12 produced in the infections site play a host defense role by inducing leukocyte migration and activation. However, these cytokines have host damaging effects when produced systemically, by inducing organ lesions (36, 37).

In the present study, we compared the role of IL-12 and IL-18 in resistance and neutrophil migration and activation (phagocytosis and microbicidal activity) in sublethal (SL) and lethal polymicrobial sepsis induced by CLP. We report that IL-18 deficiency did not affect the resistance to, and neutrophil migration and activation in, SL-CLP. In contrast, IL-12–/– mice were highly susceptible to SL-CLP. Furthermore, although neutrophils from IL-12–/– mice migrated normally during SL-CLP, they had markedly reduced phagocytosis, NO production, and microbicidal activity attributable to decreased systemic IFN-{gamma} production. Our data therefore provide direct evidence for a differential role of IL-12 and IL-18 and the mechanism of the function of IL-12 in sepsis.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 Disclosures
 References
 
Mice

Wild-type (WT) BALB/c and C57BL/6 mice, and IL-12–/– (p40–/–), IL-18–/–, and IFN-{gamma}–/– mice were used in this study. The IL-18–/– mice were as previously described (32) and the IL-12–/– were purchased from The Jackson Laboratory. WT BALB/c and C57BL/6 mice were bred in the Department of Genetics, School of Medicine of Ribeirão Preto (University of São Paulo, São Paulo, Brazil). The animals were housed in cages in temperature-controlled rooms and received food and water ad libitum. All experiments were conducted in accordance with the ethical guidelines of the School of Medicine of Ribeirão Preto, University of São Paulo.

Induction of sepsis by CLP

Sepsis was induced through CLP in mice, as previously described (38). Briefly, mice were anesthetized with tribromoethanol (250 mg/kg), a 1-cm midline incision was made on the anterior abdomen, and the cecum was exposed and ligated below the ileocecal junction without causing bowel obstruction. Three or 12 punctures were made in the cecum using a 31-gauge or 21-gauge needle to induce SL-CLP or lethal CLP sepsis, respectively. The cecum was returned to the abdomen, and the peritoneal wall and skin incision were closed. All animals received 1 ml of saline s.c. immediately after the surgery. The survival rate of mice was determined daily for 5 days after surgery. Neutrophil migration to infection focus, bacterial CFU in the exudates, cytokine levels in the exudates and serum, and neutrophil sequestration in lung tissues were determined as previously described (38).

Neutrophil migration to the peritoneal cavity

Neutrophil migration was assessed 6 h after sepsis induction. The animals were sacrificed, and cells present in the peritoneal cavity were harvested by introducing 3.0 ml of PBS containing 1 mM EDTA. Total cell counts were performed with a cell counter (Coulter AC T series analyzer), and differential cell counts were conducted on cytocentrifuge slides (Cytospin 3; Thermo Shandon) stained by the May-Grünwald-Giemsa (Rosenfeld) method. The results are expressed as the number of neutrophils per cavity.

Bacterial counts in the peritoneal exudates

Bacterial count was assessed as previously described (39). Briefly, mice were sacrificed 6 h after sepsis induction. For peritoneal lavage, peritoneal cavity was washed with 3.0 ml of sterile PBS, and aliquots of serial dilutions of these peritoneal fluids were plated on Mueller-Hinton agar dishes (Difco) and incubated at 37°C. CFU were scored after 24 h. Results were expressed as log10 of CFU per milliliter.

Cytokine assays in the peritoneal exudates and serum

TNF-{alpha} and IFN-{gamma} were determined by a double-ligand ELISA (R&D Systems) according to manufacturers’ instruction. Results are expressed as picograms per milliliter of triplicate assays.

Lung tissue myeloperoxidase activity

Myeloperoxidase activity of neutrophils in the lung tissues was measured as previously described (4). Briefly, the animals were sacrificed 6 h after sepsis induction, and lung tissue (50–100 mg) was harvested and homogenized in 2 volumes of ice-cold buffer (0.1 M NaCl, 20 mM NaPO4, and 15 mM Na EDTA (pH 4.7)), and centrifuged at 3,000 rpm for 15 min. The pellet was then subjected to hypotonic lysis (900 µl of 0.2% NaCl solution followed 30 s later by the addition of an equal volume of a solution containing 1.6% NaCl and 5% glucose). After a further centrifugation, the pellet was resuspended in 200 µl of 50 mM NaPO4 buffer (pH 5.4), containing 0.5% hexadecyltrimethylammonium bromide. The homogenate was then frozen and thawed twice and centrifuged again at 10,000 rpm for 15 min at 4°C. Myeloperoxidase activity in the resuspended pellet was assayed by measuring the change in absorbance at 450 nm using tetramethylbenzidine (1.6 mM) and H2O2 (0.5 mM). First, the results were reported as the total number of neutrophils by comparing the absorbance of the tissue supernatant with that of mouse peritoneal neutrophils processed in the same way. To this end, neutrophil migration was induced in the peritoneum of mice by injecting carrageen (300 µg). A standard curve relating neutrophil numbers (>95% purity, 12,500 to 195.3 neutrophils/50 µl) and absorbance was obtained by processing purified neutrophils as discussed and assaying for myeloperoxidase activity. The results were expressed as the number of neutrophils in 100 mg of lung tissue.

Cecal bacteria isolation

For phagocytosis and killing assays, bacteria were isolated from cecum of WT mice. Briefly, the cecum contents of three mice were removed, diluted in PBS, and filtered through sterile gauze. An aliquot of cecal content suspension was diluted in brain and heart infusion medium (Difco) and incubated for 18 h at 37°C. The suspension was centrifuged (10 min, 3000 rpm) and washed twice with PBS. The bacterial suspension was lyophilized (model CT 110; Hetovac) and stored at –70°C. All steps were performed in sterile conditions. For bacteria counts, the lyophilized contents were diluted in brain and heart infusion medium, homogenized, and incubated for 18 h at 37°C. The bacterial suspension was then centrifuged (10 min, 3000 rpm), washed twice with PBS and the final volume diluted in 10 ml of PBS. The number of CFU of the bacteria in the suspension was determined through serial log dilutions and plating on Mueller-Hinton agar dishes (Difco). CFU were counted after 18 h and the results were expressed as the number of CFU per milliliter.

Phagocytosis, killing activity, and NO production by neutrophils

Mice were injected i.p. with 1 ml of thioglycolate (3% w/v) and the peritoneal cells were harvested 6 h later by washing the cavities with RPMI 1640. Viability of cells was >98% (trypan blue exclusion) and the population consisted of macrophages and neutrophils, with the latter representing >85% of total leukocytes. Cells were cultured for 1 h at 37°C in antibiotic-free RPMI 1640, and the nonadherent cells were used as neutrophils (>94%). For the phagocytosis assay, neutrophils were incubated with cecal bacteria (1 x 107 CFU) at 37°C with gentle shaking. After 1.5 h, the cells were washed with PBS at 4°C and centrifuged at 200 x g (to remove extracellular bacteria), and then deposited onto microscope slides in a cytocentrifuge at 200 x g (Thermo Shandon), fixed with methanol, and stained by the May-Grünwald-Giemsa (Rosenfeld) method. The number of neutrophils that ingested bacteria and the number of ingested bacteria per cell were counted under a phase contrast microscope. Phagocytic index (the measure of particle uptake) was calculated: (percentage of cells containing at least one particle) x (mean number of particles per positive cell). The results are expressed as a mean of the percentage of phagocytic indexes compared with control (neutrophils from WT mice). For the killing assay, neutrophils (1 x 106/ml) were incubated with cecal bacteria (1 x 106 CFU) at 37°C with gentle shaking for 3.0 h. At the end of the incubation period, samples were pelleted by centrifugation (200 x g) and lysed by incubation in 0.2% Triton X-100. Bacterial viability was assessed by serial 10x dilutions and plating on Mueller-Hinton agar dishes (Difco); CFU were counted after 18 h and the results were expressed as the percentage of viable bacteria. For the determination of NO production by neutrophils in vitro, the production of nitrite (NO2–) was measured. Neutrophils (5 x 105 cells) were incubated with medium with or without LPS (200 ng/ml) and with or without aminoguanidine (a competitive NO synthase inhibitor, 50 µM; Alexis) for 12 h at 37°C in 5% CO2. The total amount of nitrite in the supernatants was determined using the Griess method (40). Briefly, 50 µl of supernatant samples was incubated with an equal volume of the Griess reagent at room temperature. The absorbance was measured on a plate scanner (Spectra Max 250; Molecular Devices) at 540 nm. The NO2– concentration was determined using a standard curve for 1–200 µM NaNO2.

IFN-{gamma} activation of neutrophils

Neutrophils (1 x 106) were preincubated with IFN-{gamma} (100 U/ml) for 1 h. At the end of the incubation period, the cells were incubated with cecal bacteria for phagocytosis (10 bacteria/neutrophil) and killing assays (1 bacteria/neutrophil) or stimulated with LPS (200 ng/ml) with or without aminoguanidine (50 µM) for nitrite production as described.

IFN-{gamma} treatment of IL-12–/– mice

IL-12–/– mice were injected i.p. with IFN-{gamma} (5000 U/0.2 ml; PeproTech) at 3, 12, 24, and 36 h after SL-CLP surgery and the survival of mice was recorded daily for 7 days.

Statistical analysis

The data (except for the survival curves) are reported as the mean ± SEM of values obtained from two different experiments. The mean of different treatments was compared by ANOVA. If significance was determined, individual comparisons were subsequently tested with Bonferroni’s t test for unpaired values. Bacterial counts were analyzed by the Mann-Whitney U test. The survival rate was expressed as the percentage of live animals, and Fisher’s exact test was used to determine differences between survival curves. A value of p ≤ 0.05 was considered significant. The number (n) of individual mice for each experiment is represented.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 Disclosures
 References
 
IL-12, but not IL-18, deficiency decreases resistance to SL-CLP sepsis

We examined the role of IL-12 and IL-18 in the outcome of polymicrobial septic peritonitis induced by CLP. IL-12 (p40)–/– and IL-18–/– mice and their WT controls (C57BL/6 and BALB/c mice, respectively) were exposed to SL-CLP or lethal CLP. IL-12–/– mice given SL-CLP showed 100% mortality by 96 h, whereas all WT mice survived (Fig. 1A). In contrast, all the WT and IL-18–/– mice given SL-CLP survived (Fig. 1B). The IL-12–/– mice with SL-CLP failed to control the infection with a high number of CFU in peritoneal cavity (Fig. 1C). IL-18–/– mice given SL-CLP controlled the infection as efficiently as WT mice (Fig. 1D). There was no difference between WT and IL-12–/– mice given lethal CLP, with 100% mortality and high CFU in the exudates (Fig. 1, A and C). WT and IL-18–/– mice subjected to lethal CLP also died within 72 h with high CFU in the exudates (Fig. 1, B and D).


Figure 1
View larger version (21K):
[in this window]
[in a new window]
  		FIGURE 1. Survival, bacteria count, and neutrophil migration to infection focus in IL-12–/– and IL-18–/– mice with polymicrobial sepsis. IL-12–/– and IL-18–/– and their respective WT control mice were exposed to SL-CLP or lethal CLP (L-CLP) and mortality (A and B) was monitored at regular intervals for up to 96 h. Results are expressed as the percentage of survival. *, p < 0.05 (n = 12 mice). Bacterial counts in the peritoneal fluid of IL-12–/– (C) and IL-18–/– (D) mice were performed 6 h after CLP surgery. Results are expressed as log10 of CFU per cavity (n = 4–7 mice). Horizontal bar represents the mean. *, p < 0.05 compared with WT mice. Neutrophil migration into the peritoneal cavity in IL-12–/– (E) and IL-18–/– (F) mice were performed 6 h after CLP surgery. Results are expressed as the mean ± SEM (n = 10 mice). #, p < 0.05 compared with respective SL-CLP group. Data are representative of three experiments.

 
To identify the mechanisms underlying the susceptibility of IL-12–/– mice to SL-CLP, we investigated the neutrophil recruitment toward peritoneal cavity after sepsis induction. Although IL-12–/– mice with SL-CLP failed to control the infection they showed a marked neutrophil migration into peritoneal cavity 6 h after surgery, similar to that observed in WT mice. IL-12–/– and WT mice with lethal CLP had an impaired neutrophil migration, with a 5-fold decrease of neutrophil migration compared with mice given SL-CLP (Fig. 1E). IL-18–/– mice given SL-CLP or lethal CLP had a neutrophil migration pattern similar to that observed in WT and IL-12–/– mice (Fig. 1F). These findings suggest that although the susceptibility to lethal CLP was associated with failure of neutrophil migration, the susceptibility of IL-12–/– mice to SL-CLP was not related to a deficiency in neutrophil migration to the infection foci.

IL-12–/– mice exposed to SL-CLP have increased systemic inflammatory response

High levels of systemic inflammatory cytokines as well as neutrophil sequestration into distant organs of infectious foci were used to explain the severity of sepsis. We therefore determined neutrophil sequestration in the lung and serum TNF-{alpha} levels in IL-12- and IL-18-deficient mice undergoing CLP. Neutrophil sequestration in the lung was assayed as myeloperoxidase activity. IL-12–/–, but not IL-18–/– mice, had markedly increased neutrophil sequestration in the lung compared with WT mice when exposed to SL-CLP. Neutrophil sequestration in the lungs of WT mice given lethal CLP was higher than that in WT mice given SL-CLP or sham operated (Fig. 2A). SL-CLP IL-12–/– mice, which failed to control the infection, had significantly higher concentrations of TNF-{alpha} than found in the resistant SL-CLP WT mice 6 h after surgery (Fig. 2B). In contrast, SL-CLP IL-18–/– mice, which controlled the infection, had similarly low levels of serum TNF-{alpha} as levels found in the SL-CLP WT mice. TNF-{alpha} levels in the IL-12- or IL-18-deficient mice given lethal CLP were similar to levels in lethal CLP WT mice. Together, these data show that the IL-12, but not IL-18, deficiency during SL-CLP leads to a decreased ability to restrict the infection locally and aggravated development of a systemic inflammatory response.


Figure 2
View larger version (18K):
[in this window]
[in a new window]
  		FIGURE 2. IL-12–/–, but not IL-18–/–, mice showed increased neutrophil sequestration in the lungs and increased serum TNF-{alpha} concentrations after polymicrobial sepsis. A, Neutrophil sequestration in the lungs was measured by myeloperoxidase activity 6 h after sham or CLP surgery in IL-12–/– and IL-18–/– mice, and in their respective WT controls. Results are expressed as the mean ± SEM (n = 5 mice). *, p < 0.05 compared with respective sham-operated group and #, p < 0.05 compared with WT lethal CLP group. B, Serum TNF-{alpha} concentrations were determined 6 h after CLP surgery. Results are expressed as the mean ± SEM (n = 5 mice). *, p < 0.05 compared with SL-CLP group of respective WT mice.

 
IL-12–/– neutrophils have decreased phagocytosis, microbicidal activity, and NO production

The susceptibility of SL-CLP IL-12–/– mice despite normal neutrophil migration, led us to investigate the phagocytic and microbicidal activities of the neutrophils from IL-12–/– and IL-18–/– mice. Neutrophils from IL-12–/– mice had significantly reduced phagocytosis and microbicidal activity compared with neutrophils from SL-CLP WT mice (Fig. 3A). In contrast, neutrophils from SL-CLP IL-18–/– mice had phagocytic and microbicidal activities similar to those of SL-CLP WT mice (Fig. 3B). Furthermore, neutrophils from SL-CLP IL-12–/– mice, but not SL-CLP IL-18–/– mice, produced little or no detectable NO when activated with LPS in vitro (Fig. 3, C and D). These data therefore suggest that the increase of bacterial load and mortality of SL-CLP IL-12–/– mice was likely associated with reduction of phagocytosis and bactericidal activity of neutrophils, which probably resulted from decreased NO production.


Figure 3
View larger version (29K):
[in this window]
[in a new window]
  		FIGURE 3. Neutrophils from IL-12–/–, but not IL-18–/–, mice showed decreased phagocytosis (A and B), microbicidal activity (C), and NO production (D) during polymicrobial sepsis. Neutrophils (1 x 106) were incubated in vitro with bacteria (1 or 10 bacteria/neutrophil) to evaluate phagocytosis and microbicidal activity as described in Materials and Methods. *, p < 0.05 compared with respective WT mice. For NO production, neutrophils from IL-12–/– or IL-18–/– mice were stimulated with LPS (200 ng/ml) with or without aminoguanidine (Amino, 50 µM), and medium alone (dash). Nitrite concentrations in the supernatants were determined 12 h later. Results are expressed as micromolar nitrite. *, p < 0.05 compared with respective unstimulated neutrophils and #, p < 0.05 compared with LPS-stimulated WT neutrophils. Results are the mean ± SEM (n = 4 mice) and representative of three experiments.

 
IL-12-deficient mice produce less IFN-{gamma} in SL-CLP

There is clear evidence that IL-12-induced IFN-{gamma} production is critical to the host antimicrobial defense. To determine whether the reduction of survival rate and neutrophil activation after SL-CLP in IL-12–/– mice was associated with a decrease in IFN-{gamma} production, we measured the concentrations of IFN-{gamma} in the peritoneal exudates and serum of IL-12–/– mice. Peritoneal exudates and serum from SL-CLP IL-12–/– mice contained significantly reduced concentrations of IFN-{gamma} 6 h after surgery compared with similarly treated WT mice (Fig. 4). In contrast, peritoneal exudates (Fig. 4A) and serum (Fig. 4B) from SL-CLP IL-18–/– mice contained comparable levels of IFN-{gamma} to those of the SL-CLP WT mice.


Figure 4
View larger version (20K):
[in this window]
[in a new window]
  		FIGURE 4. IL-12-, but not IL-18-, deficient mice showed reduced IFN-{gamma} production in peritoneal exudates and serum after SL-CLP. Cytokine levels in peritoneal exudates (A) and serum (B) were determined at 6 h after CLP surgery. Results are expressed as the mean ± SEM (n = 5 mice) and are representative of three experiments. #, p < 0.05 compared with WT SL-CLP group.

 
SL-CLP IFN-{gamma}–/– mice show reduced survival rate, neutrophil phagocytic and microbicidal activity, and NO production

We then investigated the direct role of IFN-{gamma} in SL-CLP. IFN-{gamma}–/– mice exposed to SL-CLP had significantly reduced survival rates compared with WT mice (Fig. 5A), despite the fact that the neutrophil migration to the infectious focus was higher in the IFN-{gamma}–/– mice than in the WT mice (Fig. 5B). Neutrophils from IFN-{gamma}–/– mice had reduced phagocytic and microbicidal activity and LPS-stimulated NO production compared with cells from the WT mice (Fig. 5, C and D). These results indicate that IL-12 and IFN-{gamma} deficiencies have a similar phenotype during SL-CLP.


Figure 5
View larger version (25K):
[in this window]
[in a new window]
  		FIGURE 5. Survival and neutrophil activities of IFN-{gamma}-deficient mice exposed to polymicrobial sepsis. A, IFN-{gamma}–/– and WT mice were exposed to CLP and mortality monitored at regular intervals. IFN-{gamma}–/– were significantly more susceptible to SL-CLP than the WT mice (n = 10 mice). A value of p < 0.05 using Mantel-Cox log rank test was obtained. B, Neutrophil migration into peritoneal cavity in WT and IFN-{gamma}–/– mice exposed to SL-CLP was determined 6 h after surgery. Results are mean ± SEM. *, p < 0.05 compared with sham-operated animals and #, p < 0.05 compared with WT SL-CLP group. C, Neutrophils (1 x 106) from WT or IFN-{gamma}–/– mice were incubated in vitro with bacteria to evaluate phagocytosis and microbicidal activity as described in Materials and Methods. Results are the mean ± SEM (n = 5 mice). *, p < 0.05 compared with WT mice. D, Neutrophils from WT or IFN-{gamma}–/– mice were stimulated with medium alone (dash) with LPS (200 ng/ml) ± aminoguanidine (Amino, 50 µM), and the concentration of nitrite in the supernatants was determined 12 h after. Results are expressed as the mean ± SEM (n = 5 mice). *, p < 0.05 compared with nonstimulated neutrophils and #, p < 0.05 compared with LPS-stimulated neutrophils from WT mice. All data are representative of two experiments.

 
IFN-{gamma} restores phagocytic and microbicidal activity, NO production, and resistance to SL-CLP of IL-12–/– mice

We then investigated whether IFN-{gamma} is able to restore the phagocytic capacity and killing activity of neutrophils from IL-12–/– mice. Neutrophils from IL-12–/– or WT mice were cultured with IFN-{gamma} for 1 h and the phagocytic and bacteria killing activity and NO production were determined. Treatment of neutrophils from IL-12–/– mice with IFN-{gamma} (100 U/ml) restored the bacterial phagocytic activity (Fig. 6A), microbicidal activity (Fig. 6B), and NO production (Fig. 6C) to levels attained in neutrophils from WT mice. The treatment of neutrophils from WT mice with recombinant IFN-{gamma} did not affect their bacterial phagocytic activity, microbicidal activity, or LPS-stimulated NO production. Furthermore, all the SL-CLP IL-12–/– mice treated with IFN-{gamma} survived the infection as in the SL-CLP WT mice (Fig. 6D). These data therefore demonstrated that the high susceptibility of IL-12–/– mice to SL-CLP was due to the deficiency in IFN-{gamma} production.


Figure 6
View larger version (24K):
[in this window]
[in a new window]
  		FIGURE 6. IFN-{gamma} restored phagocytosis, microbicidal activity, and NO production of neutrophils and reversed susceptibility of IL-12-deficient mice. Neutrophils from WT or IL-12–/– mice were preincubated in vitro with medium (dash) or 100 IU/ml of the recombinant IFN-{gamma} for 1 h, followed by incubation with bacteria. Phagocytosis (A) and microbicidal activity (B) of the neutrophils were determined as in Fig. 3. Results are the mean ± SEM (n = 4). *, p < 0.05 compared with neutrophils incubated without IFN-{gamma}. C, Neutrophils from IL-12–/– or WT mice were cultured in medium (dash) with LPS (200 ng/ml) with or without aminoguanidine (Amino, 50 µM) or with or without IFN-{gamma} (100 IU/ml), and NO production was determined as nitrite concentration in the culture supernatant 12 h later. Results are the mean ± SEM (n = 4 mice). *, p < 0.05 compared with respective nonstimulated neutrophils; #, p < 0.05 compared with neutrophils from WT mice incubated with LPS; and {diamond}, p < 0.05 compared with LPS-stimulated neutrophils from IL-12–/– mice. D, Effect of IFN-{gamma} treatment on survival of IL-12–/– mice after SL-CLP. Mice were injected i.p. with IFN-{gamma} (5000 IU) at 3, 12, 24, and 36 h after CLP surgery. The untreated IL-12–/– SL-CLP group was significantly different from WT SL-CLP mice or IFN-{gamma}-treated IL-12–/– mice. A value of p < 0.05 (n = 5) using the Mantel-Cox log rank test was obtained.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
Disclosures
 References
 
Neutrophil recruitment to the infection site is an essential step in the control of bacterial infections (2, 41). Recently, we showed that neutrophil migration is impaired in lethal sepsis induced by CLP or by S. aureus inoculation (3, 4, 5, 6, 7) and also in human sepsis (42). The impairment is associated with an ineffective bacterial clearance, leading to bacterial dissemination and high mortality. Neutrophil activation, including phagocytosis, microbicidal activity, and NO production, is also fundamental to limiting infections (43, 44, 45). In the present study, we investigated the relative roles of IL-12 and IL-18 in neutrophil migration and activation, and in disease outcome in sublethal or lethal polymicrobial sepsis induced by CLP. Data presented demonstrated that IL-12 but not IL-18 is key to the resistance of SL-CLP. Furthermore, the susceptibility of IL-12–/– mice to SL-CLP was not related to the ability of neutrophil migration to the infectious foci, but was due to a decrease in IFN-{gamma} production, leading to reduced phagocytic and microbicidal activity and NO synthesis, which were completely restored by treatment with recombinant IFN-{gamma}.

Systemic inflammatory response is considered a central deleterious pathogenic event in severe sepsis. High levels of serum inflammatory cytokines are involved in development of multiple organ failure and cardiovascular collapse (6, 46, 47). Consistent with the inability of SL-CLP IL-12–/– mice to control the infection, these mice showed elevated systemic inflammation, similar to that observed in WT mice given lethal CLP. It is important to note that neutrophil infiltration in distant organs of the infectious focus, such as lung, contributes to the tissue damage, multiple organ failure, and consequently to death of the host in the sepsis (48, 49). An earlier report showed that polyclonal anti-IL-12 Ab did not interfere with the mortality of mice given CLP or i.p. injection of live E. coli (17, 18, 19, 20). However, in these studies, the animals were under severe sepsis, a situation similar to our lethal CLP reported in this study, in which IL-12 did not appear to play a detectable role.

IFN-{gamma} can negatively regulate neutrophil migration to the inflammatory sites through the inhibition of the CXC chemokine synthesis and their receptors (46, 50) and also the expression of adhesion molecules, such as ICAM-1 (51). It is important to note that although IL-12–/– and IFN-{gamma}–/– mice had a decreased survival rate following SL-CLP, the magnitudes of the response were different. Although IL-12–/– mice showed 100% mortality within 96 h after surgery, IFN-{gamma}–/– mice exhibited only 35% mortality during this period. The increased neutrophil influx into the infection focus observed in IFN-{gamma}–/– mice (Fig. 5B) might counterbalance the reduction of the phagocytic and microbicidal activity of the neutrophils. It is important also to note that IL-12–/– mice showed a residual production of IFN-{gamma} (Fig. 4A) that may be mediated by other cytokines such IL-18 and TNF-{alpha}, which also can induce IFN-{gamma} production (13, 14, 52).

Recently, studies have demonstrated that some effects originally ascribed to IL-12 may also be mediated by IL-23, which also induces IFN-{gamma} and TNF-{alpha} production in several infections (13, 53). The p40 subunit associates not only with p35 to form IL-12p70, but also with p19, to form IL-23 (52, 54). The IL-12–/– mice used in our study are deficient in p40 and therefore were also IL-23 deficient. Thus, the reduced host defense observed in the IL-12–/– mice under SL-CLP may also be associated with reduction of IL-23. However, it was reported that mice deficient in the p35 subunit, which is present only in the IL-12 molecule, were also susceptible to bacteria infection (55). Moreover, the increase in survival rate of IL-12p40–/– mice infected with Toxoplasma gondii by treatment with IL-23 was not mediated by IFN-{gamma} but were due to IL-17 produced by NK cells and neutrophils (55). Together, our results indicate that the host deficiency observed in IL-12p40–/– mice exposed to SL-CLP might be caused by the absence of IL-12 rather than IL-23.

There are contradictory reports on the role of IL-18 in sepsis. IL-18–/– mice injected with LPS had a higher survival rate than WT mice (22). IL-1beta-converting enzyme-deficient mice, lacking the ability to process mature IL-18 and IL-1beta, were completely resistant to lethal doses of LPS derived from either E. coli or S. typhimurium. In contrast, both WT and IL-1beta–/– mice were equally susceptible to the lethal effects of LPS, implicating that absence of mature IL-18 but not IL-1beta in IL-1beta-converting enzyme-deficient mice is responsible for this resistance (33). Furthermore, the blockage of IL-18 also reduces the lethal effects of E. coli and S. typhimurium administration, which correlated with the reduction of systemic MIP-2 production and neutrophil lung infiltration (33). Our results suggest that IL-18 is not involved in the pathogenesis of SL-CLP and lethal CLP sepsis. Our results are consistent with an earlier report that endogenous IL-12 improved the early antimicrobial host response to murine E. coli (56), but are in contrast to another report that IL-18 facilitated the early antimicrobial host response to E. coli peritonitis (57). The use of different experimental models may explain the discrepancies. The CLP model used in our study is a polymicrobial model of sepsis and in the majority of the studies just described monomicrobial sepsis or endotoxemia was used.

In conclusion, the present study provides direct evidence that IL-12 and not IL-18 plays a fundamental role in both host defense in sublethal sepsis and the systemic deleterious inflammation in lethal sepsis. IL-12 acting through IFN-{gamma} is essential for mounting an efficient defense response against polymicrobial infection via increased phagocytosis, microbicidal activity, and NO production. Our results therefore provide further insight into the role of various cytokines in sepsis and clarify a key controversy on the relative role of IL-12 and IL-18 in this field.


   Acknowledgments
 
We thank Giuliana Bertozi, Fabíola Leslie Mestriner, and Ana Kátia dos Santos for technical assistance.


   Disclosures
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
References
 
The authors have no financial conflict of interest.


   Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by grants from the Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Pesquisa e Desenvolvimento Tecnológico, and Programa de Núcleos de Excelência. F.Y.L. was supported by the Medical Research Council, the Wellcome Trust, and the Chief Scientist Office, Scotland, U.K. Back

2 Address correspondence and reprint requests to Dr. Foo Y. Liew, Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, 120 University Place, University of Glasgow, Glasgow G12 8TA, U.K. E-mail address: f.y.liew{at}clinmed.gla.ac.uk Back

3 Abbreviations used in this paper: CLP, cecum ligation and puncture; SL, sublethal; WT, wild type. Back

Received for publication May 2, 2006. Accepted for publication June 12, 2006.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 

  1. Swain, S. D., T. T. Rohn, M. T. Quinn. 2002. Neutrophil priming in host defense: role of oxidants as priming agents. Antioxid. Redox Signal. 4: 69-83. [Medline]
  2. Yamashiro, S., H. Kamohara, J. M. Wang, D. Yang, W. H. Gong, T. Yoshimura. 2001. Phenotypic and functional change of cytokine-activated neutrophils: inflammatory neutrophils are heterogeneous and enhance adaptive immune responses. J. Leukocyte Biol. 69: 698-704. [Abstract/Free Full Text]
  3. Alves-Filho, J. C., C. Benjamim, B. M. Tavares-Murta, F. Q. Cunha. 2005. Failure of neutrophil migration toward infectious focus in severe sepsis: a critical event for the outcome of this syndrome. Mem. Inst. Oswaldo Cruz 100: (Suppl. 1):223-226. [Medline]
  4. Alves-Filho, J. C., A. de Freitas, M. Russo, F. Q. Cunha. 2006. Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis. Crit. Care Med. 34: 461-470. [Medline]
  5. Benjamim, C. F., S. H. Ferreira, F. Q. Cunha. 2000. Role of nitric oxide in the failure of neutrophil migration in sepsis. J. Infect. Dis. 182: 214-223. [Medline]
  6. Benjamim, C. F., J. S. Silva, Z. B. Fortes, M. A. Oliveira, S. H. Ferreira, F. Q. Cunha. 2002. Inhibition of leukocyte rolling by nitric oxide during sepsis leads to reduced migration of active microbicidal neutrophils. Infect. Immun. 70: 3602-3610. [Abstract/Free Full Text]
  7. Crosara-Alberto, D. P., A. L. Darini, R. Y. Inoue, J. S. Silva, S. H. Ferreira, F. Q. Cunha. 2002. Involvement of NO in the failure of neutrophil migration in sepsis induced by Staphylococcus aureus. Br. J. Pharmacol. 136: 645-658. [Medline]
  8. Rios-Santos, F., C. F. Benjamim, D. Zavery, S. H. Ferreira, F. Q. Cunha. 2003. A critical role of leukotriene B4 in neutrophil migration to infectious focus in cecal ligation and puncture sepsis. Shock 19: 61-65. [Medline]
  9. Canetti, C. A., B. P. Leung, S. Culshaw, I. B. McInnes, F. Q. Cunha, F. Y. Liew. 2003. IL-18 enhances collagen-induced arthritis by recruiting neutrophils via TNF-{alpha} and leukotriene B4. J. Immunol. 171: 1009-1015. [Abstract/Free Full Text]
  10. Bussolati, B., F. Mariano, A. Cignetti, A. Guarini, V. Cambi, R. Foa, G. Piccoli, G. Camussi. 1998. Platelet-activating factor synthesized by IL-12-stimulated polymorphonuclear neutrophils and NK cells mediates chemotaxis. J. Immunol. 161: 1493-1500. [Abstract/Free Full Text]
  11. Allavena, P., C. Paganin, D. Zhou, G. Bianchi, S. Sozzani, A. Mantovani. 1994. Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium. Blood 84: 2261-2268. [Abstract/Free Full Text]
  12. Puccetti, P., M. L. Belladonna, U. Grohmann. 2002. Effects of IL-12 and IL-23 on antigen-presenting cells at the interface between innate and adaptive immunity. Crit. Rev. Immunol. 22: 373-390. [Medline]
  13. Trinchieri, G.. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146. [Medline]
  14. Trinchieri, G., S. Pflanz, R. A. Kastelein. 2003. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19: 641-644. [Medline]
  15. Zwiers, A., D. Seegers, R. Heijmans, A. Koch, J. Hampe, S. Nikolaus, A. S. Pena, S. Schreiber, G. Bouma. 2004. Definition of polymorphisms and haplotypes in the interleukin-12B gene: association with IL-12 production but not with Crohn’s disease. Genes Immun. 5: 675-677. [Medline]
  16. Gran, B., N. Chu, G. X. Zhang, S. Yu, Y. Li, X. H. Chen, M. Kamoun, A. Rostami. 2004. Early administration of IL-12 suppresses EAE through induction of interferon-{gamma}. J. Neuroimmunol. 156: 123-131. [Medline]
  17. Zisman, D. A., S. L. Kunkel, R. M. Strieter, J. Gauldie, W. C. Tsai, J. Bramson, J. M. Wilkowski, K. A. Bucknell, T. J. Standiford. 1997. Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis. Shock 8: 349-356. [Medline]
  18. Steinhauser, M. L., C. M. Hogaboam, N. W. Lukacs, R. M. Strieter, S. L. Kunkel. 1999. Multiple roles for IL-12 in a model of acute septic peritonitis. J. Immunol. 162: 5437-5443. [Abstract/Free Full Text]
  19. Godshall, C. J., A. B. Lentsch, J. C. Peyton, M. J. Scott, W. G. Cheadle. 2001. STAT4 is required for antibacterial defense but enhances mortality during polymicrobial sepsis. Clin. Diagn Lab. Immunol. 8: 1044-1048. [Medline]
  20. Echtenacher, B., M. A. Freudenberg, R. S. Jack, D. N. Mannel. 2001. Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis. Infect. Immun. 69: 7271-7276. [Abstract/Free Full Text]
  21. Dinarello, C. A., G. Fantuzzi. 2003. Interleukin-18 and host defense against infection. J. Infect. Dis. 187: (Suppl. 2):S370-S384. [Medline]
  22. Sakao, Y., K. Takeda, H. Tsutsui, T. Kaisho, F. Nomura, H. Okamura, K. Nakanishi, S. Akira. 1999. IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock. Int. Immunol. 11: 471-480. [Abstract/Free Full Text]
  23. Dinarello, C. A.. 2000. Interleukin-18: a proinflammatory cytokine. Eur. Cytokine Netw. 11: 483-486. [Medline]
  24. Dinarello, C. A.. 1999. IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J. Allergy Clin. Immunol. 103: 11-24. [Medline]
  25. Puren, A. J., G. Fantuzzi, Y. Gu, M. S. Su, C. A. Dinarello. 1998. Interleukin-18 (IFN{gamma}-inducing factor) induces IL-8 and IL-1beta via TNF{alpha} production from non-CD14+ human blood mononuclear cells. J. Clin. Invest. 101: 711-721. [Medline]
  26. Stuyt, R. J., S. H. Kim, L. L. Reznikov, G. Fantuzzi, D. Novick, M. Rubinstein, B. J. Kullberg, J. W. van der Meer, C. A. Dinarello, M. G. Netea. 2003. Regulation of Staphylococcus epidermidis-induced IFN-{gamma} in whole human blood: the role of endogenous IL-18, IL-12, IL-1, and TNF. Cytokine 21: 65-73. [Medline]
  27. Gracie, J. A., R. J. Forsey, W. L. Chan, A. Gilmour, B. P. Leung, M. R. Greer, K. Kennedy, R. Carter, X. Q. Wei, D. Xu, et al 1999. A proinflammatory role for IL-18 in rheumatoid arthritis. J. Clin. Invest. 104: 1393-1401. [Medline]
  28. Pizarro, T. T., M. H. Michie, M. Bentz, J. Woraratanadharm, M. F. Smith, Jr, E. Foley, C. A. Moskaluk, S. J. Bickston, F. Cominelli. 1999. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn’s disease: expression and localization in intestinal mucosal cells. J. Immunol. 162: 6829-6834. [Abstract/Free Full Text]
  29. Greene, C. M., G. Meachery, C. C. Taggart, C. P. Rooney, R. Coakley, S. J. O’Neill, N. G. McElvaney. 2000. Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosis. J. Immunol. 165: 4718-4724. [Abstract/Free Full Text]
  30. Stober, D., R. Schirmbeck, J. Reimann. 2001. IL-12/IL-18-dependent IFN-{gamma} release by murine dendritic cells. J. Immunol. 167: 957-965. [Abstract/Free Full Text]
  31. Barbulescu, K., C. Becker, J. F. Schlaak, E. Schmitt, K. H. Meyer zum Buschenfelde, M. F. Neurath. 1998. IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-{gamma} promoter in primary CD4+ T lymphocytes. J. Immunol. 160: 3642-3647. [Abstract/Free Full Text]
  32. Wei, X. Q., B. P. Leung, W. Niedbala, D. Piedrafita, G. J. Feng, M. Sweet, L. Dobbie, A. J. Smith, F. Y. Liew. 1999. Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. J. Immunol. 163: 2821-2828. [Abstract/Free Full Text]
  33. Netea, M. G., G. Fantuzzi, B. J. Kullberg, R. J. Stuyt, E. J. Pulido, R. C. McIntyre, Jr, L. A. Joosten, J. W. Van der Meer, C. A. Dinarello. 2000. Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J. Immunol. 164: 2644-2649. [Abstract/Free Full Text]
  34. Ghayur, T., S. Banerjee, M. Hugunin, D. Butler, L. Herzog, A. Carter, L. Quintal, L. Sekut, R. Talanian, M. Paskind, et al 1997. Caspase-1 processes IFN-{gamma}-inducing factor and regulates LPS-induced IFN-{gamma} production. Nature 386: 619-623. [Medline]
  35. Lauw, F. N., A. J. Simpson, J. M. Prins, M. D. Smith, M. Kurimoto, S. J. van Deventer, P. Speelman, W. Chaowagul, N. J. White, T. van der Poll. 1999. Elevated plasma concentrations of interferon (IFN)-{gamma} and the IFN-{gamma}-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis. J. Infect. Dis. 180: 1878-1885. [Medline]
  36. Sivakumar, P. V., G. M. Westrich, S. Kanaly, K. Garka, T. L. Born, J. M. Derry, J. L. Viney. 2002. Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage. Gut 50: 812-820. [Abstract/Free Full Text]
  37. Ono, S., C. Ueno, S. Seki, A. Matsumoto, H. Mochizuki. 2003. Interleukin-12 and -18 induce severe liver injury in mice recovered from peritonitis after sublethal endotoxin challenge. Surgery 134: 92-100. [Medline]
  38. Wichterman, K. A., A. E. Baue, I. H. Chaudry. 1980. Sepsis and septic shock: a review of laboratory models and a proposal. J. Surg. Res. 29: 189-201. [Medline]
  39. Godshall, C. J., M. J. Scott, J. C. Peyton, S. A. Gardner, W. G. Cheadle. 2002. Genetic background determines susceptibility during murine septic peritonitis. J. Surg. Res. 102: 45-49. [Medline]
  40. Green, L. C., D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, S. R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126: 131-138. [Medline]
  41. Wagner, J. G., R. A. Roth. 1999. Neutrophil migration during endotoxemia. J. Leukocyte Biol. 66: 10-24. [Abstract]
  42. Tavares-Murta, B. M., M. Zaparoli, R. B. Ferreira, M. L. Silva-Vergara, C. H. Oliveira, E. F. Murta, S. H. Ferreira, F. Q. Cunha. 2002. Failure of neutrophil chemotactic function in septic patients. Crit. Care Med. 30: 1056-1061. [Medline]
  43. Burg, N. D., M. H. Pillinger. 2001. The neutrophil: function and regulation in innate and humoral immunity. Clin. Immunol. 99: 7-17. [Medline]
  44. Faurschou, M., N. Borregaard. 2003. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 5: 1317-1327. [Medline]
  45. Fierro, I. M., C. Barja-Fidalgo, F. Q. Cunha, S. H. Ferreira. 1996. The involvement of nitric oxide in the anti-Candida albicans activity of rat neutrophils. Immunology 89: 295-300. [Medline]
  46. Bone, R. C., C. J. Grodzin, R. A. Balk. 1997. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112: 235-243. [Medline]
  47. Zimecki, M., J. Artym, G. Chodaczek, M. Kocieba, M. L. Kruzel. 2004. Protective effects of lactoferrin in Escherichia coli-induced bacteremia in mice: relationship to reduced serum TNF {alpha} level and increased turnover of neutrophils. Inflamm. Res. 53: 292-296. [Medline]
  48. Collin, M., A. Rossi, S. Cuzzocrea, N. S. Patel, R. Di Paola, J. Hadley, M. Collino, L. Sautebin, C. Thiemermann. 2004. Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton. J. Leukocyte Biol. 76: 961-970. [Abstract/Free Full Text]
  49. Razavi, H. M., L. F. Wang, S. Weicker, M. Rohan, C. Law, D. G. McCormack, S. Mehta. 2004. Pulmonary neutrophil infiltration in murine sepsis: role of inducible nitric oxide synthase. Am. J. Respir. Crit. Care Med. 170: 227-233. [Abstract/Free Full Text]
  50. Robson, R. L., R. M. McLoughlin, J. Witowski, P. Loetscher, T. S. Wilkinson, S. A. Jones, N. Topley. 2001. Differential regulation of chemokine production in human peritoneal mesothelial cells: IFN-{gamma} controls neutrophil migration across the mesothelium in vitro and in vivo. J. Immunol. 167: 1028-1038. [Abstract/Free Full Text]
  51. Naik, S. M., N. Shibagaki, L. J. Li, K. L. Quinlan, L. L. Paxton, S. W. Caughman. 1997. Interferon {gamma}-dependent induction of human intercellular adhesion molecule-1 gene expression involves activation of a distinct STAT protein complex. J. Biol. Chem. 272: 1283-1290. [Abstract/Free Full Text]
  52. Trinchieri, G.. 1998. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70: 83-243. [Medline]
  53. Belladonna, M. L., J. C. Renauld, R. Bianchi, C. Vacca, F. Fallarino, C. Orabona, M. C. Fioretti, U. Grohmann, P. Puccetti. 2002. IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells. J. Immunol. 168: 5448-5454. [Abstract/Free Full Text]
  54. Oppmann, B., R. Lesley, B. Blom, J. C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, K. Singh, et al 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725. [Medline]
  55. Langrish, C. L., B. S. McKenzie, N. J. Wilson, R. de Waal Malefyt, R. A. Kastelein, D. J. Cua. 2004. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 202: 96-105. [Medline]
  56. Weijer, S., S. Florquin, T. van der Poll. 2005. Endogenous interleukin-12 improves the early anti-microbial host response to murine Escherichia coli peritonitis. Shock 23: 54-58. [Medline]
  57. Weijer, S., M. E. Sewnath, A. F. de Vos, S. Florquin, K. van der Sluis, D. J. Gouma, K. Takeda, S. Akira, T. van der Poll. 2003. Interleukin-18 facilitates the early antimicrobial host response to Escherichia coli peritonitis. Infect. Immun. 71: 5488-5497. [Abstract/Free Full Text]

Related articles in The JI:

IN THIS ISSUE

The JI 2006 177: 2737-2738. [Full Text]  



This article has been cited by other articles:


Home page
 J. Immunol.Home page
E. L. Gautier, T. Huby, F. Saint-Charles, B. Ouzilleau, M. J. Chapman, and P. Lesnik
Enhanced Dendritic Cell Survival Attenuates Lipopolysaccharide-Induced Immunosuppression and Increases Resistance to Lethal Endotoxic Shock
J. Immunol., May 15, 2008; 180(10): 6941 - 6946.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. M. Stover, J. C. Luckett, B. Echtenacher, A. Dupont, S. E. Figgitt, J. Brown, D. N. Mannel, and W. J. Schwaeble
Properdin Plays a Protective Role in Polymicrobial Septic Peritonitis
J. Immunol., March 1, 2008; 180(5): 3313 - 3318.
[Abstract] [Full Text] [PDF]

Home page
 haematolHome page
G. Cunha De Santis, M. de Barros Tamarozzi, R. B. Sousa, S. E. Moreno, D. Secco, A. B. Garcia, A. S. G. Lima, L. H. Faccioli, R. P. Falcao, F. Q. Cunha, et al.
Adhesion molecules and differentiation syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia
Haematologica, December 1, 2007; 92(12): 1615 - 1622.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. Nakano, C. Nishiyama, S. Kanada, Y. Niwa, N. Shimokawa, H. Ushio, M. Nishiyama, K. Okumura, and H. Ogawa
Involvement of mast cells in IL-12/23 p40 production is essential for survival from polymicrobial infections
Blood, June 1, 2007; 109(11): 4846 - 4855.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moreno, S. E.
Right arrow Articles by Liew, F. Y.